Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Clinical trial NCT06116110 · RECRUITING

Trial details

NCT number: NCT06116110
Sponsor: Miltenyi Biomedicine GmbH
Status: RECRUITING
Study type: OBSERVATIONAL

Non Hodgkin Lymphoma Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed Diffuse Large B Cell Lymphoma High Grade B-cell Lymphoma Central Nervous System Lymphoma Primary Mediastinal B-cell Lymphoma (PMBCL)

Start date: 2024-05-15
Primary completion: 2041-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.